Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shogo Nomura

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Journal of Biopharmaceutical Statistics|December 11, 2019
Performance of randomization-based causal methods with and without integrating external data sources for adjusting overall survival in case of extensive treatment switches in placebo-controlled randomized oncology phase 3 trialsShogo Nomura, Tomohiro Shinozaki, Chikuma Hamada
Statistics in Medicine|May 19, 2025
Adjustment of Conditional Bias in Hazard Ratios for Group Sequential Testing of Progression-Free Survival and Overall SurvivalShoki Izumi, Shogo Nomura, Yutaka Matsuyama
Statistics in Medicine|March 12, 2026
Dynamic Borrowing With a Bias-Tolerance Cap in Augmented Randomized Controlled TrialsKota Sawada, Shogo Nomura, Tomohiro Shinozaki
Journal of Biopharmaceutical Statistics|September 9, 2017
Sample size determination for the current strategy in oncology Phase 3 trials that tests progression-free survival and overall survival in a two-stage design frameworkShogo Nomura, Akihiro Hirakawa, Chikuma Hamada
Journal of Biopharmaceutical Statistics|June 22, 2026
Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation studyRyusei Kimura, Shogo Nomura, Takahiro Hasegawa, et al.
BMC Medical Research Methodology|July 30, 2024
Comparison between asymptotic and re-randomisation tests under non-proportional hazards in a randomised controlled trial using the minimisation methodRyusei Kimura, Shogo Nomura, Kengo Nagashima, et al.
Therapeutic Innovation & Regulatory Science|September 1, 2020
Study Designs in Multi-arm Trials for Breast Cancer: A Systematic Literature Review of Major JournalsShogo Nomura, Yu Miyauchi, Yoshikazu Ajisawa, et al.
JAMA Network Open|June 24, 2020
Assessment of Hazard Ratios in Oncology Clinical Trials Terminated Early for Superiority: A Systematic ReviewMasashi Shimura, Shogo Nomura, Masashi Wakabayashi, et al.
Frontiers in Oncology|December 19, 2012
Elastic laminal invasion in colon cancer: diagnostic utility and histological featuresMotohiro Kojima, Mitsuru Yokota, Norio Saito, et al.
Surgery Today|May 17, 2014
Usefulness of the neutrophil/lymphocyte ratio measured preoperatively as a predictor of peritoneal metastasis in patients with advanced gastric cancerYusuke Nakayama, Naoto Gotohda, Hidehito Shibasaki, et al.
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Journal of Biopharmaceutical Statistics|December 11, 2019
Performance of randomization-based causal methods with and without integrating external data sources for adjusting overall survival in case of extensive treatment switches in placebo-controlled randomized oncology phase 3 trialsShogo Nomura, Tomohiro Shinozaki, Chikuma Hamada
Statistics in Medicine|May 19, 2025
Adjustment of Conditional Bias in Hazard Ratios for Group Sequential Testing of Progression-Free Survival and Overall SurvivalShoki Izumi, Shogo Nomura, Yutaka Matsuyama
Statistics in Medicine|March 12, 2026
Dynamic Borrowing With a Bias-Tolerance Cap in Augmented Randomized Controlled TrialsKota Sawada, Shogo Nomura, Tomohiro Shinozaki
Journal of Biopharmaceutical Statistics|September 9, 2017
Sample size determination for the current strategy in oncology Phase 3 trials that tests progression-free survival and overall survival in a two-stage design frameworkShogo Nomura, Akihiro Hirakawa, Chikuma Hamada
Journal of Biopharmaceutical Statistics|June 22, 2026
Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation studyRyusei Kimura, Shogo Nomura, Takahiro Hasegawa, et al.
BMC Medical Research Methodology|July 30, 2024
Comparison between asymptotic and re-randomisation tests under non-proportional hazards in a randomised controlled trial using the minimisation methodRyusei Kimura, Shogo Nomura, Kengo Nagashima, et al.
Therapeutic Innovation & Regulatory Science|September 1, 2020
Study Designs in Multi-arm Trials for Breast Cancer: A Systematic Literature Review of Major JournalsShogo Nomura, Yu Miyauchi, Yoshikazu Ajisawa, et al.
JAMA Network Open|June 24, 2020
Assessment of Hazard Ratios in Oncology Clinical Trials Terminated Early for Superiority: A Systematic ReviewMasashi Shimura, Shogo Nomura, Masashi Wakabayashi, et al.
Frontiers in Oncology|December 19, 2012
Elastic laminal invasion in colon cancer: diagnostic utility and histological featuresMotohiro Kojima, Mitsuru Yokota, Norio Saito, et al.
Surgery Today|May 17, 2014
Usefulness of the neutrophil/lymphocyte ratio measured preoperatively as a predictor of peritoneal metastasis in patients with advanced gastric cancerYusuke Nakayama, Naoto Gotohda, Hidehito Shibasaki, et al.
Pageof 11